Search

everythinglearnresearchcommunity

for

Search:↓

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

A woman with a rare scalp lymphoma had unusual hair loss after treatment.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

The document explains various skin conditions and their treatments.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

CHOP chemotherapy causes many side effects but is generally well tolerated.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Herpes simplex virus infections should be considered in pemphigus patients to avoid unnecessary changes in treatment.

A woman with severe angioedema improved significantly after treatment with rituximab.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Juvenile dermatomyositis can worsen quickly and needs strong treatment.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

New treatments for lupus show promise, but more research is needed, especially for children.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.